New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis

British Journal of Dermatology

Volumn 161, Issue 6, 2009, Pages 1217-1224

  Tanaka, A ^a,b   Arita, K ^a,c   Lai Cheong, J E ^a   Palisson, F ^d   Hide, M ^b   McGrath, J A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b HIROSHIMA UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d UNIVERSIDAD DEL DESARROLLO   (Chile)

Author keywords

Amyloid; Dorsal root ganglion; Interleukin 31; Oncostatin M; Pruritus

Indexed keywords

CYTOKINE RECEPTOR; FIBRONECTIN; GLYCOPROTEIN GP 130; INTERLEUKIN 13; INTERLEUKIN 31; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; ONCOSTATIN M RECEPTOR BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

AMYLOIDOSIS; CELL TYPE; CHROMOSOME 5P; CLINICAL FEATURE; DIMERIZATION; FAMILIAL DISEASE; FAMILY HISTORY; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; HETEROZYGOSITY; HUMAN; MISSENSE MUTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PRURITUS; REVIEW; SIGNAL TRANSDUCTION; SPINAL GANGLION; TRANSCRIPTION INITIATION;

AMYLOIDOSIS, FAMILIAL; HUMANS; LINKAGE (GENETICS); MUTATION, MISSENSE; ONCOSTATIN M; ONCOSTATIN M RECEPTOR BETA SUBUNIT; PEDIGREE; PRURITUS; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; SKIN DISEASES;

EID: 72649090540     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09311.x     Document Type: Review

References (75)

1. Breathnach SM. Amyloid and amyloidosis. J Am Acad Dermatol 1988 18 : 1 16.
2. Kumakiri M, Hashimoto K. Histogenesis of primary localized cutaneous amyloidosis: sequential change of epidermal keratinocytes to amyloid via filamentous degeneration. J Invest Dermatol 1979 73 : 150 162.
3. Chang YT, Wong CK, Chow KC et al. Apoptosis in primary cutaneous amyloidosis. Br J Dermatol 1999 140 : 210 215.
4. Habermann MC, Montenegro MR. Primary cutaneous amyloidosis; clinical, laboratorial and histopathological study of 25 cases: identification of gammaglobulins and C3 in the lesions by immunofluorescence. Dermatologica 1980 160 : 240 248.
5. Arita K, South AP, Hans-Filho G et al. Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. Am J Hum Genet 2008 82 : 73 80.
6. Ramirez-Santos A, Labandiera J, Monteagudo B et al. Lichen amyloidosus without itching indicates that it is not secondary to chronic scratching. Acta Derm Venereol (Stockh) 2006 86 : 561 562.
7. Salim T, Shenoi SD, Balachandran C et al. Lichen amyloidosus: a study of clinical, histopathologic and immunofluorescence findings in 30 cases. Indian J Dermatol Venereol Leprol 2005 71 : 166 169.
8. Wang WJ, Huang CY, Chang YT et al. Anosacral cutaneous amyloidosis: a study of 10 Chinese cases. Br J Dermatol 2000 143 : 1266 1269.
9. Siragusa M, Ferri R, Cavallari V, Schepis C. Friction melanosis, friction amyloidosis, macular amyloidosis, towel melanosis: many names for the same clinical entity. Eur J Dermatol 2001 11 : 545 548.
10. Wang CK, Lee JY. Macular amyloidosis with widespread diffuse pigmentation. Br J Dermatol 1996 135 : 135 138.
11. van den Berg WH, Starink TM. Macular amyloidosis presenting as periocular hyperpigmentation. Clin Exp Dermatol 1983 8 : 195 197.
12. Black MM, Maibach HI. Macular amyloidosis simulating naevoid hyperpigmentation. Br J Dermatol 1974 90 : 461 464.
13. Bourke JF, Berth-Jones J, Burns DA. Diffuse primary cutaneous amyloidosis. Br J Dermatol 1992 127 : 641 644.
14. An HT, Han KH, Cho KH. Macular amyloidosis with an incontinentia pigmenti-like pattern. Br J Dermatol 2000 142 : 371 373.
15. Black MM. Lichen amyloidosus. An unusual clinical variant associated with the Koebner phenomenon. Acta Derm Venereol (Stockh) 1972 52 : 51 4.
16. Kuroda K, Mizoguchi M. Lichen amyloidosus with subepidermal blister formation. Eur J Dermatol 2004 14 : 262 263.
17. Bacharach-Buhles M, Schultz-Ehrenburg U, Altmeyer P. Perforating cutaneous amyloidosis. Hautarzt 1992 43 : 364 368.
18. Wolf M. Lichen amyloidosus associated with varicose veins. AMA Arch Derm Syphilol 1953 67 : 407 412.
19. Parsi K, Kossard S. Thermosensitive lichen amyloidosis. Int J Dermatol 2004 43 : 925 928.
20. Apaydin R, Bilen N, Bayramgurler D et al. Lichen amyloidosis, ankylosing spondylitis and autoimmune thyroiditis: coincidence or association? J Eur Acad Dermatol Venereol 2000 14 : 135 137.
21. Hongcharu W, Baidassano M, Gonzalez E. Generalized lichen amyloidosis associated with chronic lichen planus. J Am Acad Dermatol 2000 43 : 346 348.
22. Presbury DG, Griffiths WA. Coeliac disease with primary cutaneous amyloidosis. Br J Dermatol 1975 92 : 109 112.
23. Yalcin B, Artuz F, Toy GG et al. Generalized lichen amyloidosus associated with chronic urticaria. Dermatology 2003 207 : 203 204.
24. Shankar S, Russell-Jones R. Co-existence of lichen amyloidosus and angiolymphoid hyperplasia with eosinophilia. Clin Exp Dermatol 2004 29 : 363 365.
25. Wong CK, Lin CS. Friction amyloidosis. Int J Dermatol 1988 27 : 302 307.
26. Hashimoto K, Ito K, Kumakiri M et al. Nylon brush macular amyloidosis. Arch Dermatol 1987 123 : 633 637.
27. Goulden V, Highet AS, Sharry HK. Notalgia paraesthetica - report of an association with macular amyloidosis. Clin Exp Dermatol 1994 19 : 346 349.
28. Trattner A, David M. Textile contact dermatitis presenting as lichen amyloidosus. Contact Dermatitis 2000 42 : 107 108.
29. Venkataram MN, Bhushnurmath SR, Muirhead DE, Al-Suwaid AR. Frictional amyloidosis: a study of 10 cases. Australas J Dermatol 2001 42 : 176 179.
30. Tidman MJ, Wells RS, MacDonald DM. Pachyonychia congenita with cutaneous amyloidosis and hyperpigmentation - a distinct variant. J Am Acad Dermatol 1987 16 : 935 940.
31. Llistosella E, Moreno A, de Moragas JM. Dyskeratosis congenita with macular amyloid deposits. Arch Dermatol 1984 120 : 1381 1382.
32. Graells J, Marcoval J, Moreno A et al. Cutaneous amyloid deposits in familial palmoplantar keratoderma. J Eur Acad Dermatol Venereol 1996 6 : 87 9.
33. Danielsen L, Christensen HE, Wanstrup J. Cutaneous amyloidosis. Classification, pathogenesis and relation to 'collagen disease'. Acta Pathol Microbiol Scand [A] 1970 78 : 335 344.
34. Ogiyama Y, Hayashi Y, Kou C et al. Cutaneous amyloidosis in patients with progressive systemic sclerosis. Cutis 1996 57 : 28 32.
35. Orihara T, Yanase S, Furuya T. A case of sclerodermatomyositis with cutaneous amyloidosis. Br J Dermatol 1985 112 : 213 219.
36. Fujiwara K, Kono T, Ishii M et al. Primary localized cutaneous amyloidosis associated with autoimmune cholangitis. Int J Dermatol 2000 39 : 768 771.
37. Naldi L, Marchesi L, Locati F et al. Unusual manifestations of primary cutaneous amyloidosis in association with Raynaud's phenomenon and livedo reticularis. Clin Exp Dermatol 1992 17 : 117 120.
38. Teraki Y, Katsuta M, Shiohara T. Lichen amyloidosis associated with Kimura's disease: successful treatment with cyclosporine. Dermatology 2002 204 : 133 135.
39. Verga U, Fugazzola L, Cambiaghi S et al. Frequent association between MEN 2A and cutaneous lichen amyloidosis. Clin Endocrinol (Oxf) 2003 59 : 156 161.
40. Huilgol SC, Ramnarain N, Carrington P et al. Cytokeratins in primary cutaneous amyloidosis. Australas J Dermatol 1998 39 : 81 5.
41. LeBoit PH, Greene I. Primary cutaneous amyloidosis: identically distributed lesions in identical twins. Pediatr Dermatol 1986 3 : 244 246.
42. Lee DD, Huang JY, Wong CK et al. Genetic heterogeneity of familial primary cutaneous amyloidosis: lack of evidence for linkage with the chromosome 10 pericentromeric region in Chinese families. J Invest Dermatol 1996 107 : 30 3.
43. Lin MW, Lee DD, Lin CH et al. Suggestive linkage of familial primary cutaneous amyloidosis to a locus on chromosome 1q23. Br J Dermatol 2005 152 : 29 36.
44. Lee DD, Lin MW, Chen IC et al. Genome-wide scan identifies a susceptibility locus for familial primary cutaneous amyloidosis on chromosome 5p13.1-q11.2. Br J Dermatol 2006 155 : 1201 1208.
45. Tamura S, Morikawa Y, Tanaka M et al. Developmental expression pattern of oncostatin M receptor beta in mice. Mech Dev 2002 115 : 127 131.
46. Morikawa Y, Tamura S, Minehata K et al. Essential function of oncostatin M in nociceptive neurons of dorsal root ganglia. J Neurosci 2004 24 : 1941 1947.
47. Bando T, Morikawa Y, Komori T et al. Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns. Neuroscience 2006 142 : 1263 1271.
48. Chen S-H, Benveniste EN. Oncostatin M: a pleiotropic cytokine in the central nervous system. Cytokine Growth Factor Rev 2004 15 : 379 391.
49. Kurth I, Horsten U, Pflanz S et al. Importance of the membrane-proximal extracellular domains for activation of the signal transducer glycoprotein 130. J Immunol 2000 164 : 273 282.
50. Heinrich PC, Behrmann I, Haan S et al. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003 374 : 1 20.
51. Chattopadhyay S, Tracy E, Liang P et al. Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells. J Biol Chem 2007 282 : 3014 3026.
52. Timmermann A, Kuster A, Kurth I et al. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor. Eur J Biochem 2002 269 : 2716 2726.
53. Ng G, Winder D, Muralidhar B et al. Gain and overexpression of the oncostatin M receptor occur frequently in cervical squamous cell carcinoma and are associated with adverse clinical outcome. J Pathol 2007 212 : 325 334.
54. Morikawa Y. Oncostatin M in the development of the nervous system. Anat Sci Int 2005 80 : 53 9.
55. Boniface K, Diveu C, Morel F et al. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation. J Immunol 2007 178 : 4615 4622.
56. Auernhammer CJ, Dorn F, Viotides G et al. The oncostatin M recptor/gp130 ligand murine oncostatin M induces apoptosis in adrenocortical Y-1 tumor cells. J Endocrinol 2004 180 : 479 486.
57. Zhang Q, Putheti P, Zhou Q et al. Structure and biological functions of IL-31 and IL-31 receptors. Cytokine Growth Factor Rev 2008 19 : 347 356.
58. Dillon SR, Sprecher C, Hammond A et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004 5 : 752 760.
59. Sonkoly E, Muller A, Lauerma AI et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006 117 : 411 417.
60. Schulz F, Marenholz I, Fölster-Holst R et al. A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema. J Allergy Clin Immunol 2007 120 : 1097 1102.
61. Tamura S, Morikawa Y, Senba E. Up-regulated phosphorylation of signal transducer and activator of transcription 3 and cyclic AMP-responsive element binding protein by peripheral inflammation in primary afferent neurons possibly through oncostatin M receptor. Neuroscience 2005 133 : 797 806.
62. Maddison B, Namazi MR, Samuel LS et al. Unexpected diminished innervation of epidermis and dermoepidermal junction in lichen amyloidosus. Br J Dermatol 2008 159 : 403 406.
63. Khoo B-P, Tay Y-K, Goh C-L. Calcipotriol ointment vs betamethasone 17-valerate ointment in the treatment of lichen amyloidosis. Int J Dermatol 1999 38 : 539 541.
64. Castanedo-Cazares JP, Lepe V, Moncado B. Lichen amyloidosis improved by 0.1% topical tacrolimus. Dermatology 2002 205 : 420 421.
65. Ozkaya-Bayazit E, Baykal C, Kavak A. Local DMSO treatment of macular and papular amyloidosis. Hautarzt 1997 48 : 31 7.
66. Hudson LD. Macular amyloidosis: treatment with ultraviolet B. Cutis 1986 38 : 61 2.
67. Grimmer J, Weiss T, Weber L et al. Successful treatment of lichen amyloidosis with combined bath PUVA photochemotherapy and oral acitretin. Clin Exp Dermatol 2007 32 : 39 42.
68. Choi JY, Sippe J, Lee S. Acitretin for lichen amyloidosus. Australas J Dermatol 2008 49 : 109 113.
69. Gupta R, Gupta S. Dexamethasone-cyclophosphamide pulse therapy in lichen amyloidosis: a case report. J Dermatolog Treat 2007 18 : 249 251.
70. Drago F, Ranieri E, Pastorino A et al. Epstein-Barr virus related primary cutaneous amyloidosis and successful treatment with acyclovir and interferon-α. Br J Dermatol 1996 134 : 170 174.
71. Wong CK, Li WM. Dermabrasion for lichen amyloidosis. Report of a long-term study. Arch Dermatol 1982 118 : 302 304.
72. Ostovari N, Mohtasham N, Oadras MS et al. 532-nm and 1064-nm Q-switched Nd:YAG laser therapy for reduction of pigmentation in macular amyloidosis patches. J Eur Acad Dermatol Venereol 2008 22 : 442 446.
73. Sawamura D, Sato-Matsumura KC, Shibaki A et al. A case of lichen amyloidosis treated with pulsed dye laser. J Eur Acad Dermatol Venereol 2005 19 : 262 263.
74. Hallel-Halevy D, Finkelstein E, Grunwald MH et al. Lichen amyloidosis treated by hydrocolloid dressings. J Eur Acad Dermatol Venereol 2004 18 : 691 692.
75. Grimstad O, Sawanobori Y, Vestergaard C et al. Anti-interleukin-31- antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol 2009 18 : 35 43.